Skip to main content

and
  1. No Access

    Article

    Hepatic glucuronidation of tetrabromobisphenol A and tetrachlorobisphenol A: interspecies differences in humans and laboratory animals and responsible UDP-glucuronosyltransferase isoforms in humans

    Tetrabromobisphenol A (TBBPA) and tetrachlorobisphenol A (TCBPA), bisphenol A (BPA) analogs, are endocrine-disrupting chemicals predominantly metabolized into glucuronides by UDP-glucuronosyltransferase (UGT) ...

    Nobumitsu Hanioka, Takashi Isobe, Keita Saito, Kenjiro Nagaoka in Archives of Toxicology (2024)

  2. No Access

    Article

    Regioselective glucuronidation of daidzein in liver and intestinal microsomes of humans, monkeys, rats, and mice

    Daidzein, one of the major soy isoflavones, has a number of beneficial bioactivities for human health. It is mainly metabolized into 7- and/or 4′-glucuronides by UDP-glucuronosyltransferase (UGT) enzymes in ma...

    Nobumitsu Hanioka, Susumu Ohkawara, Takashi Isobe, Sadayuki Ochi in Archives of Toxicology (2018)

  3. No Access

    Article

    Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms

    4-tert-Octylphenol (4-tOP) is an endocrine-disrupting chemical. It is mainly metabolized into glucuronide by UDP-glucuronosyltransferase (UGT) enzymes in humans. The purpose of this study was to assess inter-indi...

    Takashi Isobe, Susumu Ohkawara, Toshiko Tanaka-Kagawa in Archives of Toxicology (2017)

  4. No Access

    Article

    Glucuronidation of 4-tert-octylphenol in humans, monkeys, rats, and mice: an in vitro analysis using liver and intestine microsomes

    4-tert-Octylphenol (4-tOP) is an endocrine-disrupting chemical. It is mainly metabolized into glucuronide by UDP-glucuronosyltransferase (UGT) enzymes in mammals. In the present study, the glucuronidation of 4-tO...

    Nobumitsu Hanioka, Takashi Isobe, Susumu Ohkawara in Archives of Toxicology (2017)

  5. No Access

    Article

    Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases

    Mono(2-ethylhexyl) phthalate (MEHP) is an active metabolite of di(2-ethylhexyl) phthalate (DEHP), which is an endocrine-disrupting chemical. In the present study, MEHP glucuronidation in humans was studied usi...

    Nobumitsu Hanioka, Yu Kinashi, Toshiko Tanaka-Kagawa in Archives of Toxicology (2017)

  6. No Access

    Article

    Hepatic and intestinal glucuronidation of mono(2-ethylhexyl) phthalate, an active metabolite of di(2-ethylhexyl) phthalate, in humans, dogs, rats, and mice: an in vitro analysis using microsomal fractions

    Mono(2-ethylhexyl) phthalate (MEHP) is an active metabolite of di(2-ethylhexyl) phthalate (DEHP) and has endocrine-disrupting effects. MEHP is metabolized into glucuronide by UDP-glucuronosyltransferase (UGT) ...

    Nobumitsu Hanioka, Takashi Isobe, Yu Kinashi in Archives of Toxicology (2016)

  7. No Access

    Article

    Functional characterization of cynomolgus monkey UDP-glucuronosyltransferase 1A9

    UDP-glucuronosyltransferase 1A9 (UGT1A9) contributes to the glucuronidation of numerous drugs. Cynomolgus monkeys are regarded as experimental animals similar to humans in studies on safety evaluation and biot...

    Kohei Yamamoto, Marina Mukai in European Journal of Drug Metabolism and Ph… (2014)

  8. No Access

    Article

    Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation

    Bisphenol A (BPA) is one of a number of potential endocrine-disrupting chemicals, which are metabolized mainly by UDP-glucuronosyltransferase 2B15 (UGT2B15) in humans. Six UGT2B15 allelic variants (UGT2B15*2, UGT...

    Nobumitsu Hanioka, Hiroyuki Oka, Kenjiro Nagaoka in Archives of Toxicology (2011)

  9. No Access

    Article

    Functional characterization of human cytochrome P450 2E1 allelic variants: in vitro metabolism of benzene and toluene by recombinant enzymes expressed in yeast cells

    Benzene and toluene are common organic solvents currently in worldwide industrial usage, which are metabolized mainly by hepatic cytochrome P450 2E1 (CYP2E1) in humans. Genetic polymorphism of CYP2E1 in 5′-flanki...

    Nobumitsu Hanioka, Maki Yamamoto, Toshiko Tanaka-Kagawa in Archives of Toxicology (2010)

  10. No Access

    Article

    S,S,S-Tris(2-ethylhexyl) phosphorotrithioate as an effective solvent mediator for a mexiletine-sensitive membrane electrode

    S,S,S-Tris(2-ethylhexyl) phosphorotrithioate proved to be an effective solvent mediator for constructing a mexiletine-sensitive membrane electrode in combination with an ion-exchanger, so...

    Takashi Katsu, Yumi Tsunamoto, Nobumitsu Hanioka in Analytical and Bioanalytical Chemistry (2007)

  11. No Access

    Protocol

    Transfection Assays With Allele-Specific Constructs

    Adverse drug reactions (ADRs) are a major clinical problem. A rapidly growing body of evidence suggests that genetic factors, at least in part, determine individual susceptibility to ADRs. A large number of ph...

    Hideto **no, Nobumitsu Hanioka, Toshiko Tanaka-Kagawa, Yoshiro Saito in Pharmacogenomics (2005)

  12. No Access

    Article

    Effect of 4-tert-octylphenol on cytochrome P450 enzymes in rat liver

    The effects were studied of 4-tert-octylphenol (OP) on hepatic cytochrome P450 enzymes in rats. Rats were treated intraperitoneally with OP twice, at doses of 5, 10, and 20 mg/kg. Among the cytochrome P450-depen...

    Nobumitsu Hanioka, Hideto **no, Youn-Son Chung in Archives of Toxicology (2000)

  13. No Access

    Article

    Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver

    We examined the effect of bisphenol A (BPA) on microsomal cytochrome P450 (P450) enzymes in rats. Rats were treated intraperitoneally with BPA daily for 4 days, at doses of 10, 20, and 40 mg/kg. Among the P45...

    Nobumitsu Hanioka, Hideto **no, Tetsuji Nishimura, Masanori Ando in Archives of Toxicology (1998)

  14. No Access

    Article

    Changes in cytochrome P450 enzymes by 1,1-dichloroethylene in rat liver and kidney

    We examined the effect of 1,1-dichloroethylene (1,1-DCE) on microsomal cytochrome P450 (P450) enzymes in rat liver and kidney. Rats were treated intraperitoneally with 1,1-DCE daily for 4 days, at doses of 20...

    Nobumitsu Hanioka, Hideto **no, Tetsuji Nishimura, Masanori Ando in Archives of Toxicology (1997)